Trials / Sponsors / Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Gli High-grade Glioma | Phase 1 | 2026-03-31 |
| Withdrawn | A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adeno Locally Advanced Breast Cancer (LABC) | Phase 1 | 2025-03-26 |
| Enrolling By Invitation | Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma. Recurrent High-grade Glioma | Phase 1 / Phase 2 | 2024-11-26 |
| Enrolling By Invitation | A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors Solid Tumor | Phase 1 | 2024-05-07 |